Clinical Trials Logo

Filter by:
NCT ID: NCT03947424 Recruiting - Snoring Clinical Trials

Clinical Tial of Er:YAG Laser Snoring Treatment

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Two modes of laser (Er:YAG) treatment for snoring will be compared with sham treatment in a randomized clinical trial.

NCT ID: NCT03938779 Recruiting - Clinical trials for Pelvic Floor Disorders

Stress Urinary Incontinence in Elite Athletes

Start date: April 25, 2019
Phase: N/A
Study type: Interventional

A protocol of pelvic floor muscles training (PFMT) in elite athletes was applied. They will do it for 4 months. Then re-evaluated.

NCT ID: NCT03937154 Recruiting - Clinical trials for Chemotherapy-induced Thrombocytopenia

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Start date: February 26, 2020
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy

NCT ID: NCT03915756 Recruiting - Clinical trials for Osteoarthritis, Knee

Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid

Start date: August 22, 2019
Phase: N/A
Study type: Interventional

The investigator's aim with this study is to address, with the new paradigm of tranexamic acid, the role of wound drainage following total knee arthroplasty in blood loss, blood transfusion requirements and functional recovery

NCT ID: NCT03900468 Recruiting - Epilepsy Clinical Trials

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

EPAS
Start date: March 5, 2020
Phase: N/A
Study type: Interventional

The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.

NCT ID: NCT03899155 Recruiting - Cancer Clinical Trials

Pan Tumor Rollover Study

Start date: August 9, 2019
Phase: Phase 2
Study type: Interventional

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

NCT ID: NCT03866603 Recruiting - Parkinson´s Disease Clinical Trials

Rostock International Parkinson's Disease Study (ROPAD)

ROPAD
Start date: May 30, 2019
Phase:
Study type: Observational

Rostock International Parkinson's Disease Study - An International, multicenter, epidemiological observational study aiming at identification of LRRK2-positive patients, the recruitment of 25,000 PD participants and the establishment of a candidate biomarker in the LRRK2-positive cohort.

NCT ID: NCT03849586 Recruiting - Clinical trials for Erectile Dysfunction

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

PHOENIX
Start date: November 19, 2021
Phase:
Study type: Observational [Patient Registry]

Prospective collection of pre-defined parameters on the surgical treatment of male erectile dysfunction using Penile Prosthesis Implants (PPIs).

NCT ID: NCT03836040 Recruiting - Migraine Clinical Trials

Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine

OASIS(EM)
Start date: July 19, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with episodic migraine. The study hypothesis is that in pediatric participants with episodic migraine, the combined erenumab dose group has a greater reduction from baseline to week 9 through week 12 (month 3) in monthly migraine days (MMDs) when compared with placebo in the double-blind treatment phase (DBTP).

NCT ID: NCT03819075 Recruiting - Peri-Implantitis Clinical Trials

Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis

Start date: March 3, 2018
Phase: N/A
Study type: Interventional

A laser treatment for periimplantitis using two different wavelengths (Er:YAG and Nd:YAG) will be compared to standard treatment in a randomized clinical trial.